Metraipolis › archive › dc_f562154b6477

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac — Europe PMC PMID:42455315

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42455315
DOI
10.1007/s00259-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-18T06:38:36.912Z
SHA-256 of the archived text
20da5e5eccaf2e3141de2ced8d5be6ca259875611bb547d1e2508b1227fb678f
Stable URL of this page
https://metraipolis.com/documento/dc_f562154b6477

How to cite

Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac — Europe PMC PMID:42455315 — Europe PMC (en), https://europepmc.org/article/MED/42455315 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f562154b6477 (Metraipolis archive dc_f562154b6477, sha256 20da5e5eccaf2e3141de2ced8d5be6ca259875611bb547d1e2508b1227fb678f)
BibTeX
@misc{dcf562154b6477,
  title = {Predicting tumour and organ dose in α-radiopharmaceutical therapy: a 89Zr-based dosimetric approach for 225Ac — Europe PMC PMID:42455315},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42455315},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f562154b6477; sha256 20da5e5eccaf2e3141de2ced8d5be6ca259875611bb547d1e2508b1227fb678f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42455315. Agents can read the archived copy with the MCP tool read_document.